| Bioactivity | Naltiazem (Ro 23-6152) is a thiazepinone-type calcium antagonist. Naltiazem inhibits platelet aggregation in vitro and in vivo[1]. |
| CAS | 108383-95-5 |
| Formula | C26H28N2O4S |
| Molar Mass | 464.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. L A Sordahl, et al. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152). J Cardiovasc Pharmacol. 1991 Oct;18(4):504-10. |
Naltiazem
CAS: 108383-95-5 F: C26H28N2O4S W: 464.58
Naltiazem (Ro 23-6152) is a thiazepinone-type calcium antagonist. Naltiazem inhibits platelet aggregation in vitro and i
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.